Drug and Chemical Toxicology · 2008 · 18 citations · 21 references
MedicinePharmacologyToxicologyFood ToxicologyNutritional ToxicologyProstate DiseaseLipid AnalysisLipid MetabolismAcute Oral ToxicityAndrogenic ToxicityAnimal Weight GainHistopathological LesionsHistopathological ResponseOrgan Weight AssessmentOrgan Weight MeasurementSubchronic Neurotoxicity
D-004 is a lipid extract of royal palm (Rosytonea regia) fruits that prevents prostate hyperplasia induced with testosterone in rodents. Previous studies have shown no D-004-related toxicity in rats, but no study in mice had been reported. D-004 (500, 1000, and 2000 mg/kg) was evaluated in a subchronic (eight weeks) study in NMRI mice. No evidences of treatment-related toxicity were detected. Thus, body-weight gain, clinical observations, food consumption, blood biochemical, hematology, organ-weight ratios, and histopathological findings were similar in control and treated groups. This study supports that D-004 orally administered up to 2000 mg/kg did not induce treatment-related toxicity.
21
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
Glenn J. Gormley, Elizabeth Stoner, Reginald C. Bruskewitz et al. · New England Journal of Medicine · 1992 · 1.1K citations · Full text
Medicine, Endocrinology, Urology +17
The role of dihydrotestosterone in benign prostatic hyperplasia
Culley C. Carson, Roger S. Rittmaster · Urology · 2003 · 393 citations
Medicine, Endocrinology, Urology +10
Jean-Christophe Carraro, Jean-Pierre Raynaud, Gary G. Koch et al. · The Prostate · 1996 · 342 citations
Principles and methods of toxicology
H.C. Krebs · Toxicon · 1995 · 327 citations
Pharmacy, Pharmacology, Toxicology +10